The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The fragile X mental retardation protein is associated with ribosomes
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMRP co-IP’d with rpP0-containing complexes, as did the ribosomal proteins rpL5 and rpS6 (Figure 7H), demonstrating a direct association of FMRP with ribosome-containing complexes, reminiscent of previous findings in cultured cells (Khandjian et al., 1996; Siomi et al., 1996).”
From FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism (2011) · cites this paper as Khandjian et al., 1996
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Instability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,108
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n
Kremer, E., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S., Schlessinger, D., Sutherland, G., & Richards, R. (1991) · Science · doi:10.1126/science.1675488 · Cited by 929
Devys, D., Lutz, Y., Rouyer, N., Bellocq, J., & Mandel, J. (1993) · Nature Genetics · doi:10.1038/ng0893-335 · Cited by 781
Ross, M. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-2-286_5 · Cited by 758
FMR1 Protein: Conserved RNP Family Domains and Selective RNA Binding
Ashley, C. T., Wilkinson, K. D., Reines, D., & Warren, S. T. (1993) · Science · doi:10.1126/science.7692601 · Cited by 752
Lerner, E. A., Lerner, M. R., Janeway, C. A., & STEITZ, J. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.2737 · Cited by 718
DNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Research works printed but not linked: 2
- Goodwin, G.H. & Dahlberg, A.E. Electrophoresis of nucleoproteins. In Gel electrophoresis of nucleic acids: a practical approach, (eds Rickwood, D. & Hames, B.D.) 199–225 (IRL Press, Oxford, 1982).
- Schwartz, J.H. Synthesis and trafficking of neuronal proteins. In Principles of neuronal science, (eds Kandel, E.R., Schwartz, J.H. & Jessell, T.M.) (Appleton Lange,Norwalk,1992).
Cited by
Sorted by citations
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
Ramboz, S., Oosting, R. S., Amara, D. A., Kung, H. F., Blier, P., Mendelsohn, M. M., Mann, J. J., Brunner, D., & Hen, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14476 · Cited by 831
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676
Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644
Zhang, Y., Bailey, A. M., Matthies, H. J. G., Renden, R., Smith, M. A., Speese, S. D., Rubin, G. M., & Broadie, K. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00589-x · Cited by 651
Feng, Y., Gutekunst, C.-A., Eberhart, D. E., Yi, H., Warren, S. T., & Hersch, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01539.1997 · Cited by 532
Feng, Y., Absher, D., Eberhart, D. E., Brown, V., Malter, H. E., & Warren, S. T. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80012-x · Cited by 511
A Decade of Molecular Studies of Fragile X Syndrome
O'Donnell, W. T., & Warren, S. T. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142909 · Cited by 487
From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475
Eberhart, D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1083 · Cited by 390
The molecular biology of FMRP: new insights into fragile X syndrome
Richter, J. D., & Zhao, X. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00432-0 · Cited by 390
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370
Mazrouï, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.24.3007 · Cited by 369
Translational control in synaptic plasticity and cognitive dysfunction
Buffington, S. A., Huang, W., & Costa-Mattioli, M. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014100 · Cited by 348
Shrimpton, A. E., Daly, K. M., & Hoo, J. J. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990528)84:3 · Cited by 20
RNA and microRNAs in fragile X mental retardation
Jin, P., Alisch, R. S., & Warren, S. T. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1048 · Cited by 344
Fragile X mice develop sensory hyperreactivity to auditory stimuli
Chen, L., & Toth, M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00036-7 · Cited by 345
BRCA1 interacts with components of the histone deacetylase complex
Yarden, R. I., & Brody, L. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4983 · Cited by 328
Phosphorylation influences the translation state of FMRP-associated polyribosomes
Ceman, S., O'Donnell, W. T., Reed, M., Patton, S., Pohl, J., & Warren, S. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg350 · Cited by 327
Trinucleotide Repeats: Mechanisms and Pathophysiology
Cummings, C. J., & Zoghbi, H. Y. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.281 · Cited by 326
Paradee, W., Melikian, H. E., Rasmussen, D. L., Kenneson, A., Conn, P. J., & Warren, S. T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00285-7 · Cited by 305
Darnell, J. C., Fraser, C. E., Mostovetsky, O., Stefani, G., Jones, T. A., Eddy, S. R., & Darnell, R. B. (2005) · Genes & Development · doi:10.1101/gad.1276805 · Cited by 287
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
Peier, A. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1145 · Cited by 285
Wan, L., Dockendorff, T. C., Jongens, T. A., & Dreyfuss, G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8536-8547.2000 · Cited by 280
Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells
Stefani, G., Fraser, C. E., Darnell, J. C., & Darnell, R. B. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2306-04.2004 · Cited by 274
Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions
Nussbacher, J. K., Tabet, R., Yeo, G. W.-M., & Lagier‐Tourenne, C. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.014 · Cited by 271
Siomi, M. C., Zhang, Y., Siomi, H., & Dreyfuss, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3825 · Cited by 271
Vries, B. B. A. D., Halley, D. J. J., Oostra, B. A., & Niermeijer, M. F. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.7.579 · Cited by 262
Toward Fulfilling the Promise of Molecular Medicine in Fragile X Syndrome
Krueger, D. D., & Bear, M. F. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-061109-134644 · Cited by 259
Fragile X Mental Retardation Protein Regulates Translation by Binding Directly to the Ribosome
Chen, E., Sharma, M. R., Shi, X., Agrawal, R. K., & Joseph, S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.023 · Cited by 253
Corbin, F. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1465 · Cited by 239
Self-citationRNA TRANSPORT AND LOCAL CONTROL OF TRANSLATION
Kindler, S., Wang, H., Richter, D., & Tiedge, H. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120653 · Cited by 215
The State of Synapses in Fragile X Syndrome
Pfeiffer, B. E., & Huber, K. M. (2009) · The Neuroscientist · doi:10.1177/1073858409333075 · Cited by 216
Molecular Insights into mRNA Transport and Local Translation in the Mammalian Nervous System
Kiebler, M. A., & DesGroseillers, L. (2000) · Neuron · doi:10.1016/s0896-6273(00)80868-5 · Cited by 202
Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis
Tamanini, F. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1315 · Cited by 206
Brown, V., Small, K. M., Lakkis, L., Feng, Y., Gunter, C., Wilkinson, K. D., & Warren, S. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15521 · Cited by 192
The ubiquitous nature of RNA chaperone proteins
Cristofari, G., & Darlix, J. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)72071-0 · Cited by 179
Khandjian, E. W., Huot, M.-E., Tremblay, S., Davidovic, L., Mazroui, R., & Bardoni, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405398101 · Cited by 178
The GABAA receptor: a novel target for treatment of fragile X?
D’Hulst, C., & Kooy, R. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.003 · Cited by 166
Darnell, J. C., Fraser, C., Mostovetsky, O., & Darnell, R. B. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp255 · Cited by 160
McConkie‐Rosell, A., Finucane, B. M., Cronister, A., Abrams, L. J., Bennett, R. L., & Pettersen, B. J. (2005) · Journal of Genetic Counseling · doi:10.1007/s10508-005-0002-3 · Cited by 159
Chen, L., Yun, S.-W., Seto, J., Liu, W., & Toth, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00406-8 · Cited by 160
Xu, D., Shen, W., Guo, R., Xue, Y., Peng, W., Sima, J., Yang, J., Sharov, A. A., Srikantan, S., Yang, J., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3479 · Cited by 148
A mouse model of the human Fragile X syndrome I304N mutation
Zang, J. B., Nosyreva, E. D., Spencer, C. M., Volk, L. J., Musunuru, K., Zhong, R., Stone, E. F., Yuva-Paylor, L. A., Huber, K. M., Paylor, R., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000758 · Cited by 138
FMRP is associated to the ribosomes via RNA
Tamanini, F. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.6.809 · Cited by 143
Larson, J., Jessen, R. E., Kim, D., Fine, A.-K. S., & du Hoffmann, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2638-05.2005 · Cited by 135
A nuclear role for the Fragile X mental retardation protein.
Fridell, R. A., Benson, R. E., Hua, J., Bogerd, H. P., & Cullen, B. R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00924.x · Cited by 131
Cytoplasmic RNA-Binding Proteins and the Control of Complex Brain FunctionPreprint
Darnell, J. C., & Richter, J. D. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012344 · Cited by 127
Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model
Heulens, I., D’Hulst, C., Dam, D. V., Deyn, P. P. D., & Kooy, R. F. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.031 · Cited by 125
Chen, T., & Richard, S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4863 · Cited by 123
Knockout mouse model for Fxr2: a model for mental retardation
Bontekoe, C. J. M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.487 · Cited by 120
Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP
Dolzhanskaya, N., Merz, G., Aletta, J. M., & Denman, R. B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02882 · Cited by 119
Santini, E., & Klann, E. (2014) · Science Signaling · doi:10.1126/scisignal.2005832 · Cited by 118
MOV10 and FMRP Regulate AGO2 Association with MicroRNA Recognition Elements
Kenny, P., Zhou, H., Kim, M., Skariah, G., Khetani, R. S., Drnevich, J. M., Arcila, M. L., Kosik, K. S., & Ceman, S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.054 · Cited by 121
Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA
Blackwell, E., Zhang, X., & Ceman, S. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq007 · Cited by 117
TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules
Goulet, I., Boisvenue, S., Mokas, S., Mazrouï, R., & Côté, J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn203 · Cited by 118
Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis
Khandjian, E. W. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2121 · Cited by 114
Self-citationFragile X Syndrome: from molecular pathology to therapy
Maurin, T., Zongaro, S., & Bardoni, B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.006 · Cited by 113
Tamanini, F., Bontekoe, C. J. M., Bakker, C. E., van Unen, L., Anar, B., Willemsen, R., Yoshida, M., GALJAARD, H., Oostra, B. A., & Hoogeveen, A. T. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.863 · Cited by 113
Smart, F. M., Aschrafi, A., Atkins, A. R., Owens, G. C., Pilotte, J., Cunningham, B. A., & Vanderklish, P. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04521.x · Cited by 111
Fatimy, R. E., Davidovic, L., Tremblay, S., Jaglin, X. H., Dury, A. Y., Robert, C., Koninck, P. D., & Khandjian, É. W. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006192 · Cited by 114
Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome
Scharf, S. H., Jaeschke, G., Wettstein, J. G., & Lindemann, L. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.11.004 · Cited by 106
Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons
Tabet, R., Moutin, E., Becker, J. A. J., Heintz, D., Fouillen, L., Flatter, E., Krężel, W., Alunni, V., Koebel, P., Dembélé, D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522631113 · Cited by 112
McNicoll, F., Müller-McNicoll, M., Cloutier, S., Boilard, N., Rochette, A., Dubé, M., & Papadopoulou, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507511200 · Cited by 100
The fragile X syndrome: exploring its molecular basis and seeking a treatment
Bardoni, B., Davidovic, L., Bensaid, M., & Khandjian, É. W. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406010751 · Cited by 106
Adinolfi, S., Bagni, C., Musco, G., Gibson, T. J., Mazzarella, L., & Pastore, A. (1999) · RNA · doi:10.1017/s1355838299990647 · Cited by 96
Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation
Qin, M., Kang, J. Y., & Smith, C. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242377399 · Cited by 93
LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathway
Liu, L., Yue, H., Liu, Q., Yuan, J., Li, J., Wei, G., Chen, X., Lu, Y., Guo, M., Luo, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7487 · Cited by 91
Shah, S., Molinaro, G., Liu, B., Wang, R., Huber, K. M., & Richter, J. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.076 · Cited by 95
Sung, Y. J., Dolzhanskaya, N., Nolin, S. L., Brown, T., Currie, J. R., & Denman, R. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211117200 · Cited by 89
Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein
Bhogal, B., Jepson, J. E. C., Savva, Y. A., Pepper, A. S.-R., Reenan, R. A., & Jongens, T. A. (2011) · Nature Neuroscience · doi:10.1038/nn.2950 · Cited by 87
Tamanini, F., van Unen, L., Bakker, C. E., Sacchi, N., GALJAARD, H., Oostra, B. A., & Hoogeveen, A. T. (1999) · Biochemical Journal · doi:10.1042/bj3430517 · Cited by 91
Understanding fragile X syndrome: insights from animal models
Bakker, C. E., & Oostra, B. A. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072845 · Cited by 90
Molecular and cellular genetics of fragile X syndrome
Kaufmann, W. E., & Reiss, A. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1 · Cited by 88
Siomi, M. C., Higashijima, K., Ishizuka, A., & Siomi, H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8438-8447.2002 · Cited by 85
Disordered RNA chaperone proteins: from functions to disease
Iványi-Nagy, R., Davidovic, L., Khandjian, E. W., & Darlix, J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5100-9 · Cited by 82
Self-citationMazrouï, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg335 · Cited by 82
Kozikowski, A. P., Shen, S., Pardo, M., Tavares, M. T., Szarics, D., Benoy, V., Zimprich, C., Kutil, Z., Zhang, G., Bařinka, C., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00600 · Cited by 81
Analysis of Domains Affecting Intracellular Localization of the FMRP Protein
Bardoni, B., Sittler, A., Shen, Y., & Mandel, J. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0142 · Cited by 80
Biology of the fragile X mental retardation protein, an RNA-binding protein
Khandjian, É. W. (1999) · Biochemistry and Cell Biology · doi:10.1139/bcb-77-4-331 · Cited by 81
Fragile X syndrome at the turn of the century
Kooy, R. F., Willemsen, R., & Oostra, B. A. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01674-9 · Cited by 80
Widespread Alterations in Translation Elongation in the Brain of Juvenile Fmr1 Knockout Mice
Sharma, S. D., Metz, J. B., Li, H., Hobson, B. D., Hornstein, N. J., Sulzer, D., Tang, G., & Sims, P. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.086 · Cited by 71
The fragile X mental retardation protein has nucleic acid chaperone properties
Gabus, C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh535 · Cited by 74
The genetic basis of cognition
Flint, J. (1999) · Brain · doi:10.1093/brain/122.11.2015 · Cited by 77
La Protein Is Associated with Terminal Oligopyrimidine mRNAs in Actively Translating Polysomes
Cardinali, B., Carissimi, C., Gravina, P., & Pierandrei‐Amaldi, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300722200 · Cited by 73
Ribosomal RNA 2′-O-methylation dynamics impact cell fate decisions
Häfner, S. J., Jansson, M., Altinel, K., Andersen, K. L., Abay-Nørgaard, Z., Ménard, P., Fontenas, M., Sørensen, D. M., Gay, D. M., Arendrup, F. S., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.06.007 · Cited by 72
The RNA-binding protein Gemin5 binds directly to the ribosome and regulates global translation
Francisco‐Velilla, R., Fernández-Chamorro, J., Ramajo, J., & Martı́nez-Salas, E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw702 · Cited by 71
Musumeci, S. A., Calabrese, G., Bonaccorso, C. M., D'Antoni, S., Brouwer, J. R., Bakker, C. E., Elia, M., Ferri, R., Nelson, D. L., Oostra, B. A., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.007 · Cited by 70
Castrén, M. L., & Ċastrén, E. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.018 · Cited by 68
Verma, V., Paul, A., Vishwanath, A. A., Vaidya, B., & Clement, J. P. (2019) · Open Biology · doi:10.1098/rsob.180265 · Cited by 68
Fathoming fragile X in fruit flies
Zhang, Y., & Broadie, K. S. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.11.003 · Cited by 66
Fragile X mental retardation protein: A paradigm for translational control by RNA-binding proteins
Chen, E., & Joseph, S. (2015) · Biochimie · doi:10.1016/j.biochi.2015.02.005 · Cited by 66
Mutter, M., Wöhr, T., Gioria, S., & Keller, M. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(1999)51:2 · Cited by 79
Kunde, S., Musante, L., Grimme, A., Fischer, U., Müller, E., Wanker, E. E., & Kalscheuer, V. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr430 · Cited by 68
Alternative Splicing in the Murine and Human FXR1 Genes
Kirkpatrick, L., McIlwain, K. A., & Nelson, D. L. (1999) · Genomics · doi:10.1006/geno.1999.5868 · Cited by 63
Zanotti, K. J., Lackey, P. E., Evans, G. L., & Mihailescu, M. (2006) · Biochemistry · doi:10.1021/bi060209a · Cited by 62
Drouin, R., Angers, M., Dallaire, N., Rose, T. M., Khandjian, E. W., & Rousseau, F. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2051 · Cited by 62
Self-citationScreening for fragile X syndrome.
Murray, Cuckle, Taylor, & Hewison (1997) · Health Technology Assessment · doi:10.3310/hta1040 · Cited by 60
Metadata
- Authors
- Khandjian, E. W., Corbin, F., Woerly, S., & Rousseau, F.
- Affiliations
- Hôpital Saint-François d'Assise (CA)
- Venue
- Nature Genetics
- Published
- 1996-01
- Volume
- 12
- Issue
- 1
- Pages
- 91-93
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2026456570
- Cited by
- 251
- References
- 30
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 10 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 12 · 2013: 8 · 2012: 5
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- FMRP, fragile X syndrome, ribosome association, 60S ribosomal subunit, CGG repeat expansion, FMR1 gene silencing, RNA-binding proteins, translation machinery, neurons, polysomes
- MeSH terms
- Animals, Cell Compartmentation, Fragile X Syndrome, HeLa Cells, Humans, Nerve Tissue Proteins, Protein Binding, Ribosomes, Protein Biosynthesis, 3T3 Cells, RNA-Binding Proteins, Fluorescent Antibody Technique, Indirect, Mice, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review